License To Fill: Pipeline Top AstraZeneca Priority Under Brennan

AstraZeneca's plans to bolster its product pipeline include further efforts to tap external technology sources, according to CEO David Brennan

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet